JJ Singleton was a 27-year-old athlete from the small Appalachian town in North Carolina, when he was diagnosed with aggressive colorectal cancer. His story highlights the alarming rise of early-onset colorectal cancer, a disease now the leading cause of cancer death for men under 50.
Growing up in a rural community where going to the doctor was often avoided and early death was dismissed as “God’s will,” JJ wasn’t diagnosed with colon cancer until a visible tumor throbbed in his abdomen. His journey from brutal chemotherapy failures to a life-stabilizing immunotherapy clinical trial at Duke is a powerful testament to the promise of precision medicine—turning terminal cancer into a manageable chronic condition.
Yet, his story also exposes a critical cancer care disparity: the immense difficulty rural patients face in accessing the very trials that could save them. This episode explores how geography, limited resources, and a lack of knowledge about accessing healthcare as a preventative strategy creates an intimidating barrier between rural Americans and cutting-edge care.
Key Takeaways:
- Early-Onset Crisis: Colorectal cancer is rising dramatically in adults under 50 and is now a leading cause of cancer death in this age group.
- Rural Disparity: Where you live is a major social determinant of health, creating significant barriers to screening, specialist care, and life-saving clinical trials.
- Chronic Disease Potential: Immunotherapy and precision medicine trials are beginning to successfully turn some advanced, active cancers into controllable chronic conditions.
We amplify Colorectal Cancer Awareness Month with JJ’s personal advocacy to a national conversation on prevention, breaking stigma, and the systemic changes needed to bridge the gap to precision medicine for every patient, regardless of their zip code.
